Auraleafs Labs Profile
Key Indicators
- Authorised Capital ₹ 18.00 Cr
as on 22-12-2024
- Paid Up Capital ₹ 10.56 Cr
as on 22-12-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 24.60 Cr
as on 22-12-2024
- Revenue 81.41%
(FY 2021)
- Profit 88.15%
(FY 2021)
- Ebitda 519.47%
(FY 2021)
- Net Worth -5.58%
(FY 2021)
- Total Assets -0.45%
(FY 2021)
About Auraleafs Labs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 18.00 Cr and a paid-up capital of Rs 10.56 Cr.
The company currently has active open charges totaling ₹24.60 Cr.
Krishna Vallabhaneni and Madhavi Donepudi serve as directors at the Company.
- CIN/LLPIN
U24296TG2018PTC123345
- Company No.
123345
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Auraleafs Labs Private Limited offer?
Auraleafs Labs Private Limited offers a wide range of products and services, including Fresh, Dried & Preserved Fruits, Citrus Fruits, Ayurvedic & Herbal Extracts, Plant Extracts.
Who are the key members and board of directors at Auraleafs Labs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madhavi Donepudi  | Director | 26-Mar-2018 | Current |
Krishna Vallabhaneni  | Director | 25-Apr-2018 | Current |
Financial Performance of Auraleafs Labs.
Auraleafs Labs Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 81.41% increase. The company also saw a substantial improvement in profitability, with a 88.15% increase in profit. The company's net worth dipped by a decrease of 5.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Auraleafs Labs?
In 2021, Auraleafs Labs had a promoter holding of 14.29% and a public holding of 85.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 30 Nov 2018 | ₹24.60 Cr | Open |
How Many Employees Work at Auraleafs Labs?
Auraleafs Labs has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Auraleafs Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Auraleafs Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
